Enovix Target of Unusually High Options Trading (NASDAQ:ENVX)

Enovix Corporation (NASDAQ:ENVX) was the target of unusually large options trading on Thursday. Investors purchased 24,162 call options on the stock. This is an increase of approximately 48% compared to the typical daily volume of 16,356 call options.

Key Enovix News

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix’s Q1 results beat revenue expectations and the company reported a smaller-than-expected loss, while management highlighted revenue growth and strategic progress on the earnings call. Enovix Corp (ENVX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Alignments
• Positive Sentiment: Unusually heavy call option activity suggests some traders are betting on a rebound in Enovix shares. Enovix (NASDAQ:ENVX) Price Target Cut to $21.00 by Analysts at Oppenheimer
• Neutral Sentiment: Oppenheimer, Benchmark, Craig Hallum, and TD Cowen all reduced their price targets on Enovix, but most still kept constructive ratings, signaling lower valuation expectations rather than a full thesis change. Enovix (NASDAQ:ENVX) Given New $15.00 Price Target at Benchmark Enovix (NASDAQ:ENVX) Price Target Lowered to $8.00 at Craig Hallum Enovix (NASDAQ:ENVX) Price Target Cut to $7.00 by Analysts at TD Cowen
• Negative Sentiment: Investors are also focused on Enovix’s widening losses and the uncertain timeline for commercialization, which appeared to weigh on the stock after earnings. Enovix sinks as losses widen; commercialization timeline remains in focus

Analysts Set New Price Targets

ENVX has been the subject of a number of recent research reports. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday. B. Riley Financial cut their target price on Enovix from $17.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, March 2nd. Wells Fargo & Company set a $6.00 price target on shares of Enovix in a research report on Thursday, March 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a report on Friday, April 10th. Finally, Bank of America began coverage on shares of Enovix in a research report on Thursday, March 12th. They issued a “neutral” rating and a $6.00 price objective on the stock. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $12.64.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Enovix by 10.9% in the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after purchasing an additional 1,747,145 shares during the period. Millennium Management LLC raised its stake in shares of Enovix by 1,038.9% in the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock worth $14,724,000 after buying an additional 1,347,200 shares in the last quarter. Two Sigma Investments LP raised its stake in shares of Enovix by 9,197.1% in the 3rd quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock worth $11,974,000 after buying an additional 1,188,079 shares in the last quarter. Barclays PLC lifted its holdings in shares of Enovix by 263.1% in the fourth quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock valued at $11,345,000 after buying an additional 1,124,480 shares during the period. Finally, Electron Capital Partners LLC lifted its holdings in shares of Enovix by 13.8% in the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after buying an additional 972,103 shares during the period. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Stock Performance

ENVX stock traded down $0.19 during trading on Friday, reaching $6.11. 7,744,125 shares of the company’s stock were exchanged, compared to its average volume of 6,558,571. Enovix has a 1-year low of $4.61 and a 1-year high of $16.49. The firm has a market cap of $1.33 billion, a PE ratio of -7.36 and a beta of 2.24. The company’s fifty day moving average price is $5.82 and its 200-day moving average price is $7.10. The company has a quick ratio of 8.13, a current ratio of 8.34 and a debt-to-equity ratio of 1.90.

Enovix (NASDAQ:ENVX) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The company had revenue of $7.60 million for the quarter, compared to analyst estimates of $6.95 million. Enovix had a negative return on equity of 63.25% and a negative net margin of 499.64%.The company’s quarterly revenue was up 49.1% compared to the same quarter last year. During the same period last year, the company earned ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, research analysts expect that Enovix will post -0.81 EPS for the current fiscal year.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.